492 related articles for article (PubMed ID: 36293076)
1. Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
Hu L; Napoletano A; Provenzano M; Garofalo C; Bini C; Comai G; La Manna G
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293076
[TBL] [Abstract][Full Text] [Related]
2. Impact of Cinacalcet and Etelcalcetide on Bone Mineral and Cardiovascular Disease in Dialysis Patients.
Bernardor J; De Mul A; Bacchetta J; Schmitt CP
Curr Osteoporos Rep; 2023 Apr; 21(2):193-204. PubMed ID: 36848027
[TBL] [Abstract][Full Text] [Related]
3. Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.
Wesseling-Perry K; Salusky IB
Pediatr Nephrol; 2013 Apr; 28(4):617-25. PubMed ID: 23381010
[TBL] [Abstract][Full Text] [Related]
4. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
[TBL] [Abstract][Full Text] [Related]
5. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
[TBL] [Abstract][Full Text] [Related]
6. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Hsu CY; Chen LR; Chen KH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
[TBL] [Abstract][Full Text] [Related]
8. Pediatric CKD-MBD: existing and emerging treatment approaches.
Ayoob RM; Mahan JD
Pediatr Nephrol; 2022 Nov; 37(11):2599-2614. PubMed ID: 35038008
[TBL] [Abstract][Full Text] [Related]
9. Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients.
Karaboyas A; Muenz D; Fuller DS; Desai P; Lin TC; Robinson BM; Rossetti S; Pisoni RL
Am J Kidney Dis; 2022 Mar; 79(3):362-373. PubMed ID: 34273436
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels.
Haffner D; Leifheit-Nestler M
Pediatr Nephrol; 2020 Mar; 35(3):485-491. PubMed ID: 31823044
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperphosphatemia: the dangers of high PTH levels.
Bacchetta J
Pediatr Nephrol; 2020 Mar; 35(3):493-500. PubMed ID: 31696357
[TBL] [Abstract][Full Text] [Related]
13. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study.
Magagnoli L; Cozzolino M; Caskey FJ; Evans M; Torino C; Porto G; Szymczak M; Krajewska M; Drechsler C; Stenvinkel P; Pippias M; Dekker FW; de Rooij ENM; Wanner C; Chesnaye NC; Jager KJ;
Nephrol Dial Transplant; 2023 Oct; 38(11):2562-2575. PubMed ID: 37230954
[TBL] [Abstract][Full Text] [Related]
14. [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy].
Bellasi A; Cozzolino M; Malberti F; Cancarini G; Esposito C; Genderini A; Guastoni CM; Ondei P; Pontoriero G; Teatini U; Vezzoli G; Messa P; Locatelli F
G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786181
[TBL] [Abstract][Full Text] [Related]
15. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
Molony DA; Stephens BW
Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
[TBL] [Abstract][Full Text] [Related]
16. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R
Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines.
Bover J; Massó E; Gifre L; Alfieri C; Soler-Majoral J; Fusaro M; Calabia J; Rodríguez-Pena R; Rodríguez-Chitiva N; López-Báez V; Sánchez-Baya M; da Silva I; Aguilar A; Bustos MC; Rodrigues N; Chávez-Iñiguez JS; Romero-González G; Valdivielso JM; Molina P; Górriz JL
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049415
[TBL] [Abstract][Full Text] [Related]
20. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients.
Hasparyk UG; Vigil FMB; Bartolomei VS; Nunes VM; Simões E Silva AC
Curr Med Chem; 2022 Aug; 29(31):5230-5253. PubMed ID: 35306980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
